John McMichael
52Patents
18h-index
8Co-inventors
77Inventor score
Filing activity: Jul 30, 1979 → Dec 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6294171A | Methods for treating disease states comprising administration of low levels of antibodies | Human Necessities | 97 | Expired |
| US5753624A | Materials and methods for treatment of plaquing disease | Chemistry; Metallurgy | 92 | Expired |
| US6187309A | Method for treatment of symptoms of central nervous system disorders | Human Necessities | 76 | Expired |
| US6020314A | Methods for treatment of neurological disorders | Human Necessities | 68 | Expired |
| US6581606B2 | Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response | Physics | 58 | Expired |
| US4880626A | Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome | Human Necessities | 38 | Expired |
| US4966753A | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms | Human Necessities | 34 | Expired |
| US4692332A | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms | Human Necessities | 33 | Expired |
| US4689222A | Methods and materials for alleviation of pain symptoms of malignant neoplasia | Human Necessities | 32 | Expired |
| US5798102A | Treatment of cardiomyopathy | Human Necessities | 30 | Expired |
| US6575169B2 | Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug | Physics | 24 | Expired |
| US4970071A | Immunotherapeutic methods and compositions employing antigens characteristic of non human malignant neoplasms | Human Necessities | 23 | Expired |
| US5365948A | Method for use in treating a patient with FK 506 to prevent an adverse immune response | Human Necessities | 21 | Expired |
| US4294818A | Methods and materials for detection of multiple sclerosis | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6267116A | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug | Human Necessities | 20 | Expired |
| US4704273A | Methods and materials for treatment of rheumatoid arthritis | Emerging Cross-Sectional Technologies | 19 | Expired |
| US4877610A | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms | Human Necessities | 19 | Expired |
| US5610136A | Method for treatment of benign prostatic hypertrophy | Human Necessities | 18 | Expired |
| US5726160A | Methods for treating respiratory disease | Human Necessities | 17 | Expired |
| US5694950A | Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response | Human Necessities | 16 | Expired |
| US6581607B2 | Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response | Human Necessities | 16 | Expired |
| US6713058B2 | Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies | Human Necessities | 14 | Expired |
| US5955442A | Methods for treating respiratory disease | Human Necessities | 13 | Expired |
| US4705685A | Methods and materials for treatment of disease states involving immunological factors | Human Necessities | 13 | Expired |
| US6436401B1 | Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies | Human Necessities | 13 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.